Literature DB >> 24201039

False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: a case control study.

Ryan C Maves1, Katherine Dean2, Nilda Gadea3, Eric S Halsey3, Paul C F Graf4, Andres G Lescano3.   

Abstract

Non-treponemal tests such as the rapid plasma reagin (RPR) assay are mainstays of syphilis diagnosis, but false-positive tests are common. We identified false-positive RPR titers in 8.2% of patients with malaria due to Plasmodium vivax in northern Peru. Similar rates were not detected in patients with other acute febrile illnesses. Published by Elsevier Ltd.

Entities:  

Keywords:  Diagnostic test; Syphilis; Vivax malaria

Mesh：

Substances：

Year:  2013        PMID： 24201039      PMCID： PMC4041835          DOI： 10.1016/j.tmaid.2013.10.010

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN： 1477-8939            Impact factor:   6.211


  29 in total

1.  It is time to use treponema-specific antibody screening tests for diagnosis of syphilis.

Authors:  Michael J Loeffelholz; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

2.  Serological tests for syphilis in treated Plasmodium falciparum malaria.

Authors:  M G NELSON
Journal:  Trans R Soc Trop Med Hyg       Date:  1947-09       Impact factor: 2.184

Review 3.  Which algorithm should be used to screen for syphilis?

Authors:  Matthew J Binnicker
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

4.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

Review 5.  Laboratory diagnosis and interpretation of tests for syphilis.

Authors:  S A Larsen; B M Steiner; A H Rudolph
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon.

Authors:  Falgunee K Parekh; Jean N Hernandez; Donald J Krogstad; W Martin Casapia; Oralee H Branch
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

Review 7.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

8.  Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.

Authors:  G Snounou; S Viriyakosol; W Jarra; S Thaithong; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

Review 9.  Human T-cell responses to blood stage antigens in Plasmodium falciparum malaria.

Authors:  M Troye-Blomberg
Journal:  Immunol Lett       Date:  1994-07       Impact factor: 3.685

10.  Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis.

Authors:  David C Mabey; Kimberly A Sollis; Helen A Kelly; Adele S Benzaken; Edward Bitarakwate; John Changalucha; Xiang-Sheng Chen; Yue-Ping Yin; Patricia J Garcia; Susan Strasser; Namwinga Chintu; Tikki Pang; Fern Terris-Prestholt; Sedona Sweeney; Rosanna W Peeling
Journal:  PLoS Med       Date:  2012-06-12       Impact factor: 11.069
View more
  3 in total

1.  A clinical audit of maternal syphilis in a regional hospital in KwaZulu-Natal, South Africa.

Authors:  Onankoy A Onyangunga; Thajasvarie Naicker; Jagidesa Moodley
Journal:  S Afr J Infect Dis       Date:  2020-04-30

2.  Syphilis Laboratory Guidelines: Performance Characteristics of Nontreponemal Antibody Tests.

Authors:  Susan Tuddenham; Samantha S Katz; Khalil G Ghanem
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

3.  Prevalence of reproductive tract infections among women preparing to conceive in Chongqing, China: trends and risk factors.

Authors:  Jun Liu; Mengyao Zeng; Liu Yang; Yanyan Mao; Yang He; Min Li; Qing Chen; Weijin Zhou; Liang Chen; Qianxi Zhu
Journal:  Reprod Health       Date:  2022-10-03       Impact factor: 3.355
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.